[Cystic pancreatic lesions-indications, timing and reasons for surveillance]

Marlies Vornhülz,Simon Sirtl,Elisabeth Orgler,Maximilian Weniger,Jörg Schirra,Georg Beyer,Julia Mayerle

DOI: https://doi.org/10.1007/s00117-023-01226-4

Abstract:Background: Cystic pancreatic lesions are detected incidentally at an increasing rate. Often, the patients present asymptomatically. Hence, the resulting clinical consequences remain challenging and unsettling for both physicians and patients. Objectives: Status of current recommendations in handling cystic pancreatic lesions. Materials and methods: Selective literature search of PubMed while taking current guidelines into account. Results: Correct diagnostic classification of the cystic lesion is crucial since further action depends on the type of cystic lesion. Resection is generally recommended for mucinous cystic neoplasms (MCN), solid pseudopapillary neoplasms (SPN), and intraductal papillary mucinous neoplasms (IPMN) with relevant risk criteria such as prominent main-duct dilation. Surveillance is recommended for IPMN without risk criteria, as long as comorbidities and life expectancy of the patient will allow preventive resection over the years. SCNs are benign and only symptomatic SCNs require resection. Inflammatory pancreatic cysts should only be treated under certain circumstances.